159 related articles for article (PubMed ID: 36706349)
1. National Cancer Grid Virtual Tumor Boards of Head and Neck Cancers: An Innovative Approach to Multidisciplinary Care.
Thiagarajan S; Poojari V; Tuljapurkar V; Ghosh-Laskar S; Fatehi K; Babu S; Penumadu P; Patil A; Joshi A; Kumar S; Chaukar D; Kannan R; Pramesh CS
JCO Glob Oncol; 2023 Jan; 9():e2200348. PubMed ID: 36706349
[TBL] [Abstract][Full Text] [Related]
2. The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges.
Ekhator C; Kesari S; Tadipatri R; Fonkem E; Grewal J
Cureus; 2022 Jun; 14(6):e25682. PubMed ID: 35677741
[TBL] [Abstract][Full Text] [Related]
3. Assessing the feasibility of a virtual tumor board program: a case study.
Shea CM; Teal R; Haynes-Maslow L; McIntyre M; Weiner BJ; Wheeler SB; Jacobs SR; Mayer DK; Young M; Shea TC
J Healthc Manag; 2014; 59(3):177-93. PubMed ID: 24988672
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular Carcinoma.
Salami AC; Barden GM; Castillo DL; Hanna M; Petersen NJ; Davila JA; Naik AD; Anaya DA
J Oncol Pract; 2015 Jan; 11(1):e66-74. PubMed ID: 25466708
[TBL] [Abstract][Full Text] [Related]
5. Virtual Tumor Boards for Remote Learning in Head and Neck Surgical Oncology.
Papazian MR; Chow M; Weed D; Liu JC; Bewley AF; Moore MG; Givi B
JAMA Otolaryngol Head Neck Surg; 2023 Oct; 149(10):899-903. PubMed ID: 37615974
[TBL] [Abstract][Full Text] [Related]
6. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the clinical impact of a multidisciplinary head and neck tumor board.
Wheless SA; McKinney KA; Zanation AM
Otolaryngol Head Neck Surg; 2010 Nov; 143(5):650-4. PubMed ID: 20974334
[TBL] [Abstract][Full Text] [Related]
8. Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia).
Harsh KK; Maharia SR; Nirban RK; Khatri P; Beniwal S; Kumar HS; Jakhar SL
J Cancer Res Ther; 2020; 16(3):559-564. PubMed ID: 32719267
[TBL] [Abstract][Full Text] [Related]
9. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Kong A; Ahmed SK
J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
[TBL] [Abstract][Full Text] [Related]
10. Differentiating recurrent tumours from post-treatment changes in head and neck cancers: does diffusion-weighted MRI solve the eternal dilemma?
Vaid S; Chandorkar A; Atre A; Shah D; Vaid N
Clin Radiol; 2017 Jan; 72(1):74-83. PubMed ID: 27789026
[TBL] [Abstract][Full Text] [Related]
11. Barriers in Access to Care for Patients With Head and Neck Cancer in Resource-Limited Settings: A Systematic Review.
Beaudoin PL; Anchouche S; Gaffar R; Guadagno E; Ayad T; Poenaru D
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):291-297. PubMed ID: 31944228
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central European Cooperative Oncology Group (CECOG).
Thallinger C; Berzinec P; Bicakcic E; Dan A; Fabian G; Gales LN; Kuhar CG; Janzic U; Kahan Z; Mencinger M; Penthedourakis G; Sgouros J; Simetic L; Sirbu D; Vosmik M; Wrona A; Zielinski C
Wien Klin Wochenschr; 2022 Oct; 134(19-20):697-704. PubMed ID: 35312859
[TBL] [Abstract][Full Text] [Related]
13. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a regional virtual tumor board: a prospective study evaluating feasibility and provider acceptance.
Marshall CL; Petersen NJ; Naik AD; Vander Velde N; Artinyan A; Albo D; Berger DH; Anaya DA
Telemed J E Health; 2014 Aug; 20(8):705-11. PubMed ID: 24845366
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).
Mañós M; Giralt J; Rueda A; Cabrera J; Martinez-Trufero J; Marruecos J; Lopez-Pousa A; Rodrigo JP; Castelo B; Martínez-Galán J; Arias F; Chaves M; Herranz JJ; Arrazubi V; Baste N; Castro A; Mesía R
Oral Oncol; 2017 Jul; 70():58-64. PubMed ID: 28427761
[TBL] [Abstract][Full Text] [Related]
17. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers.
Trama A; Licitra L; Cavalieri S; Bonfarnuzzo S; Baili P; Ciarfella A; Parente P; Almadori G; Ansarin M; Bacigalupo A; Baumeister P; Baujat B; Bossi P; Cavalera E; Cercato MC; Dieleman F; Fakhry N; Ferraresi V; Gaino F; Galizia D; Halamkova J; Halme E; Hardillo J; Hofauer B; Kinloch E; Livi L; Locati LD; Mattheis S; Mercante G; Mirabile A; Molteni G; Orlandi E; Persio R; Sciallero S; Smeele L; Tagliabue M; Valentini V; Van Harpen C; Westphalen CB; Botta L
PLoS One; 2023; 18(3):e0283071. PubMed ID: 36928072
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
20. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Grünwald V; Chirovsky D; Cheung WY; Bertolini F; Ahn MJ; Yang MH; Castro G; Berrocal A; Sjoquist K; Kuyas H; Auclair V; Guillaume X; Joo S; Shah R; Harrington K;
Oral Oncol; 2020 Mar; 102():104526. PubMed ID: 31978755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
